Finally, in ovarian cancer, TLR2 expressed on CD44+/MyD88+ CSCs promotes their self-renewal and induces the secretion of pro-inflammatory cytokines, thus actively contributing to tumor repair following injury induced by surgery or chemotherapy [79]. Here, MYD88 is linked to neoplasm.